When testing new treatments, drugmakers must show that their formulation bears out better results than a placebo in clinical trials. In fact, the new drug must outperform the placebo by a ...
Your editorial “The FDA Returns to Its Bad Habits” (Feb. 21) explains, “Reata’s p-value was 0.014, which means there was a 1.4% chance that its positive result was a fluke.” A related, true statement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback